COCRYSTAL PHARMA INC

Frost Gamma’s latest 75,000‑share buy of Cocrystal Pharma at $0.94 signals renewed insider confidence, pairing fresh capital and rising buzz for a potential breakout.

Insider buying spurs confidence in Cocrystal Pharma (CRP) as executives accumulate shares ahead of key norovirus data, suggesting a potential upside for investors.